Gene Therapy Is Booming, But How Will We Manage The Costs? – Forbes
ForbesGene Therapy Is Booming, But How Will We Manage The Costs?ForbesBluebird has a while to go before it has to grapple with pricing, though it did make headlines in October, when it published results from a small trial of its gene therapy to treat t… Continue reading
